| The global phosphorylation landscape of SARS-CoV-2 infection M Bouhaddou, D Memon, B Meyer, KM White, VV Rezelj, MC Marrero, ... Cell 182 (3), 685-712. e19, 2020 | 890 | 2020 |
| Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms DE Gordon, J Hiatt, M Bouhaddou, VV Rezelj, S Ulferts, H Braberg, ... Science 370 (6521), eabe9403, 2020 | 635 | 2020 |
| Evolution of enhanced innate immune evasion by SARS-CoV-2 LG Thorne, M Bouhaddou, AK Reuschl, L Zuliani-Alvarez, B Polacco, ... Nature, 1-12, 2021 | 381 | 2021 |
| Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A KM White, R Rosales, S Yildiz, T Kehrer, L Miorin, E Moreno, S Jangra, ... Science 371 (6532), 926-931, 2021 | 304 | 2021 |
| A protein interaction landscape of breast cancer M Kim, J Park, M Bouhaddou, K Kim, A Rojc, M Modak, M Soucheray, ... Science 374 (6563), eabf3066, 2021 | 91 | 2021 |
| Global landscape of the host response to SARS-CoV-2 variants reveals viral evolutionary trajectories M Bouhaddou, AK Reuschl, BJ Polacco, LG Thorne, MR Ummadi, C Ye, ... bioRxiv, 2022 | 11 | 2022 |
| A Whole-Genome CRISPR Screen Identifies AHR Loss as a Mechanism of Resistance to a PARP7 Inhibitor H Chen, ME Diolaiti, PC O'Leary, A Rojc, NJ Krogan, M Kim, A Ashworth Molecular Cancer Therapeutics 21 (7), 1076-1089, 2022 | 8 | 2022 |
| HIV transcription is independent of mediator kinases DC Cary, M Rheinberger, A Rojc, BM Peterlin AIDS Research and Human Retroviruses 35 (8), 710-717, 2019 | 7 | 2019 |
| Evolution of enhanced innate immune evasion by SARS-CoV-2 (vol 602, pg 487, 2022) LG Thorne, M Bouhaddou, AK Reuschl, L Zuliani-Alvarez, B Polacco, ... NATURE 604 (7905), E14-E14, 2022 | 5* | 2022 |
| Comparative host-coronavirus protein interaction networks reveal panviral disease mechanisms. Science 370: eabe9403 DE Gordon, J Hiatt, M Bouhaddou, VV Rezelj, S Ulferts, H Braberg, ... | 4 | 2020 |
| A whole genome CRISPR screen identifies AHR loss as a mechanism of PARP7 inhibitor resistance H Chen, ME Diolaiti, PC O'Leary, A Rojc, NJ Krogan, M Kim, A Ashworth Molecular Cancer Therapeutics, 2022 | | 2022 |
| Aktivnost katepsinov C, L, B in S v modelu diferenciarnih črevesnih epitelijskih celic Caco-2: magistrsko delo A Rojc A. Rojc, 2018 | | 2018 |
| Karakterizacija komercialno dostopnih oblik proteina G in testiranje vpliva sestave raztopin na stabilnost teh proteinov A Rojc A. Rojc, 2014 | | 2014 |
